Decades of work on chronic obstructive pulmondary disease (COPD) at the Jacobs School of Medicine and Biomedical Sciences and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the bacterial pathogen that does the most harm to patients.
Evaluation of a Specific Cytotoxic Agent and Identification of a New Targetable Receptor for Human TripleNegative Breast Cancer. Terry Connell (Co-Investigator). Dept. of Defense, BCRP, Breakthrough Award Levels 1. $375,000. 4/1/2018-3/1/2020.